Bristol-Myers Squibb revenue and financials

BMY · NYSE · USD

$59.31+0.85%+$0.50

Close · October 6, 2026

In the fiscal year ended December 2025, Bristol-Myers Squibb reported revenue of $48.19B (−0.22% year over year). Net income was $7.05B, a net margin of 14.6%.

Annual revenue · 2025: $48.19B

$19.43B2016
$20.78B2017
$22.56B2018
$26.15B2019
$42.52B2020
$46.39B2021
$46.16B2022
$45.01B2023
$48.3B2024
$48.19B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth: −0.22%; 2025 vs 2024
Net margin: 14.6%; 2024: -18.5%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total revenue	48,194	48,300	45,006	46,159	46,385	42,518	26,145	22,561	20,776	19,427
Cost of revenue	13,936	13,968	10,693	10,137	9,940	11,773	8,078	6,467	6,014	4,969
Gross profit	35,000	36,351	34,377	36,022	36,445	30,745	18,067	16,094	14,682	14,481
Selling, general and administrative	7,152	7,865	7,678	7,777	7,655	—	—	—	—	—
Research and development	9,951	11,159	9,299	9,509	10,195	10,048	6,148	6,332	6,468	5,012
Operating income	15,039	9,832	8,365	9,141	8,572	—	—	—	—	—
EBIT	15,039	9,832	8,365	9,141	8,572	—	—	—	—	—
EBITDA	19,116	19,407	18,134	19,423	19,329	—	—	—	—	—
Interest expense	1,892	1,958	1,166	1,232	1,334	1,420	656	183	196	167
Pre-tax income	9,328	-8,379	8,440	7,713	8,098	—	—	—	—	—
Income tax	2,272	554	400	1,368	1,084	2,124	1,515	1,021	4,156	1,408
Net income	7,054	-8,948	8,025	6,327	6,994	-9,015	3,439	4,920	1,007	4,457
Net income to common shareholders	7,054	-8,948	8,025	6,327	6,994	—	—	—	—	—
Basic EPS	3.47	-4.41	3.88	2.97	3.15	-3.99	2.02	3.01	0.61	2.67
Diluted EPS	3.46	-4.41	3.86	2.95	3.12	-3.99	2.01	3.01	0.61	2.65
Average shares (basic)	2,034	2,027	2,069	2,130	2,221	—	—	—	—	—
Average shares (diluted)	2,039	2,027	2,078	2,146	2,245	2,258	1,712	1,637	1,652	1,680
Dividend per share	2.49	2.42	2.31	2.19	2.01	—	—	—	—	—